The Latest Breaking News on Diabetes

More than half of adults will also be overweight or have obesity in the same timeframe, researchers say

Researchers are calling for urgent action and global policy reforms to address widespread global obesity pandemic by 2050.

Dispatches looks at the rise of appetite suppressants for weight loss in the health and beauty industries. Plus: Frankenstein at the National Theatre. Here’s what to watch this evening

Study predicts nation on course to have second-highest overweight and obesity rates in world but says urgent government reform could help avoid this

Analysis forecasts a third of young people will also be overweight or obese, in ‘unparalleled’ threat to health

Experts said the global picture represents a ‘profound tragedy and a monumental societal failure’

Experts claim that Ozempic, a drug originally developed to treat diabetes, has become a Hollywood secret weapon.

Hims & Hers Health put out a jaw dropping commercial. Now, Hims stock is just dropping, as its semaglutide business faces a setback.

Glucose monitors are increasingly used by people without diabetes to monitor diet choices

Weight-loss drugs aren’t just slimming waists; they create a $100 billion market opportunity. With plenty up for grabs, pharmaceutical giants like Eli Lilly and Company (LLY), Novo Nordisk (NVO), and Amgen (AMGN) are betting big on next-generation weight loss treatments to dominate this booming market. Keeping reading.

The medical director of the NHS has warned of the side effects of weight loss drugs after figures revealed the number of deaths associated with the jabs